Literature DB >> 10403462

Expression of cell cycle and apoptosis-related proteins in sporadic odontogenic keratocysts and odontogenic keratocysts associated with the nevoid basal cell carcinoma syndrome.

L Lo Muzio1, S Staibano, G Pannone, P Bucci, P F Nocini, E Bucci, G De Rosa.   

Abstract

Odontogenic keratocysts are occasionally (4-5%) associated with the nevoid basal cell carcinoma syndrome, a pleiotropic, autosomal disorder presenting a spectrum of developmental abnormalities and a predisposition for the development of different neoplasms. The aim of this study was to establish whether keratocysts showing clinically aggressive behavior associated with nevoid basal cell carcinoma syndrome reflect differences in cellular proliferation rate and/or in the expression of oncoproteins and tumor suppressor genes. For this reason, formalin-fixed paraffin-embedded sections of odontogenic keratocysts associated with the nevoid basal cell carcinoma syndrome (16 cases) and sporadic odontogenic keratocysts (16 cases) were compared for expression of proliferating cell nuclear antigen (PCNA) and p53, bcl-2, and bcl-1 (cyclin D1) onco-proteins. Most of the epithelial lining of odontogenic keratocysts associated with the nevoid basal cell carcinoma syndrome showed nuclear immunopositivity for p53 protein and overexpression of cyclin D1 with various degrees of staining intensity. All sporadic odontogenic keratocysts were negative for p53 and cyclin D1. The expressions of bcl-2 oncoprotein were found to be substantially similar between the two groups of lesions, with a cytoplasmic immunopositivity localized only in the resting reserve basal layer of the epithelium. PCNA expression showed no statistically significant difference between the two groups of lesions. In conclusion, the finding of cyclin D1 and p53 overexpression in odontogenic keratocysts associated with the nevoid basal cell carcinoma syndrome could be considered a hallmark of a mutated cellular phenotype, thus leading to the hypothesis that their aggressive clinical behavior could be due to a dysregulation of the expression of cyclin D1 and p53 proteins, involved in a check-point control of cellular proliferation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10403462     DOI: 10.1177/00220345990780070901

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  20 in total

Review 1.  Size distribution and clinicoradiological signs of aggressiveness in odontogenic myxoma-three-dimensional analysis and systematic review.

Authors:  Martin Kauke; Ali-Farid Safi; Matthias Kreppel; Andrea Grandoch; Hans-Joachim Nickenig; Joachim E Zöller; Timo Dreiseidler
Journal:  Dentomaxillofac Radiol       Date:  2017-11-06       Impact factor: 2.419

2.  Odontogenic epithelium: immunolabeling of Ki-67, EGFR and survivin in pericoronal follicles, dentigerous cysts and keratocystic odontogenic tumors.

Authors:  Márcia Gaiger de Oliveira; Isabel da Silva Lauxen; Anna Cecília Moraes Chaves; Pantelis Varvaki Rados; Manoel Sant'Ana Filho
Journal:  Head Neck Pathol       Date:  2010-10-30

3.  miR-15a/16-1 influences BCL2 expression in keratocystic odontogenic tumors.

Authors:  Marina Gonçalves Diniz; Carolina Cavaliéri Gomes; Wagner Henriques de Castro; André Luiz Sena Guimarães; Alfredo Maurício Batista De Paula; Hope Amm; Chanchung Ren; Mary MacDougall; Ricardo Santiago Gomez
Journal:  Cell Oncol (Dordr)       Date:  2012-06-09       Impact factor: 6.730

4.  Altered expression of cell-cell adhesion molecules β-catenin/E-cadherin and related Wnt-signaling pathway in sporadic and syndromal keratocystic odontogenic tumors.

Authors:  Samer George Hakim; Hartwig Kosmehl; Peter Sieg; Thomas Trenkle; Hans-Christian Jacobsen; Geza Attila Benedek; Julika Ribbat; Oliver Driemel
Journal:  Clin Oral Investig       Date:  2010-02-27       Impact factor: 3.573

5.  A Case of Gorlin-Goltz Syndrome Presented With Multiple Odontogenic Keratocysts in the Jaw Without Skin Manifestation.

Authors:  A Rupesh Rao; Amar Taksande
Journal:  Cureus       Date:  2022-05-02

6.  Two modifications in the treatment of keratocystic odontogenic tumors (KCOT) and the use of Carnoy's solution (CS)--a retrospective study lasting between 2 and 10 years.

Authors:  Martin Gosau; Florian G Draenert; Steffen Müller; Bernhard Frerich; Ralf Bürgers; Thorsten E Reichert; Oliver Driemel
Journal:  Clin Oral Investig       Date:  2009-03-18       Impact factor: 3.573

7.  Expression of Ki-67, p53 and p63 proteins in keratocyst odontogenic tumours: an immunohistochemical study.

Authors:  Clarissa Araújo Silva Gurgel; Eduardo Antônio Gonçalves Ramos; Roberto Almeida Azevedo; Viviane Almeida Sarmento; Ana Maria da Silva Carvalho; Jean Nunes dos Santos
Journal:  J Mol Histol       Date:  2008-02-07       Impact factor: 2.611

8.  Immunohistochemical expression of cyclin D1 in ameloblastomas and adenomatoid odontogenic tumors.

Authors:  Harish Kumar; R Vandana; Gs Kumar
Journal:  J Oral Maxillofac Pathol       Date:  2011-09

9.  Novel PTCH1 mutations in patients with keratocystic odontogenic tumors screened for nevoid basal cell carcinoma (NBCC) syndrome.

Authors:  Lorenza Pastorino; Annamaria Pollio; Giovanni Pellacani; Carmelo Guarneri; Paola Ghiorzo; Caterina Longo; William Bruno; Francesca Giusti; Sara Bassoli; Giovanna Bianchi-Scarrà; Cristel Ruini; Stefania Seidenari; Aldo Tomasi; Giovanni Ponti
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

10.  Expression of Bcl-2 and epithelial growth factor receptor proteins in keratocystic odontogenic tumor in comparison with dentigerous cyst and ameloblastoma.

Authors:  Seyed Mohammad Razavi; Nakisa Torabinia; Mohammad Reza Mohajeri; Shahriyar Shahriyary; Shirin Ghalegolab; Samin Nouri
Journal:  Dent Res J (Isfahan)       Date:  2015 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.